Invention Grant
- Patent Title: Bridged bicyclic kallikrein inhibitors
-
Application No.: US15807331Application Date: 2017-11-08
-
Publication No.: US10144746B2Publication Date: 2018-12-04
- Inventor: Zhe Li , Manuel Zancanella , Chul Yu , Lina Q. Setti , Hing Sham , Qing Xu , Calvin W. Yee , Ming Yu
- Applicant: GLOBAL BLOOD THERAPEUTICS, INC.
- Applicant Address: US CA South San Francisco
- Assignee: Global Blood Therapeutics, Inc.
- Current Assignee: Global Blood Therapeutics, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Knobbe, Martens, Olson & Bear, LLP
- Main IPC: C07D519/00
- IPC: C07D519/00 ; C07D405/12 ; C07D307/81 ; C07D491/18 ; C07D493/08 ; C07D471/08 ; C07D213/73 ; C07B59/00 ; C07D401/12 ; C07D487/08
Abstract:
Provided herein are kallikrein modulating compounds, pharmaceutical compositions comprising the same, and uses thereof.
Public/Granted literature
- US20180194780A1 BRIDGED BICYCLIC KALLIKREIN INHIBITORS Public/Granted day:2018-07-12
Information query
